ArticleMolecular therapy. Oncology2025
Targeted degradation of KRAS and induction of bystander effects by a modular bioPROTAC.
Shojiro Inano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ArticleMolecular therapy. Oncology2025
Shojiro Inano et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.